🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Ovarii › Ohio › Toledo

Qorannoo klinikaalii Kansarii Ovarii Toledo, OH keessatti

Qorannoo 12 Kansarii Ovarii f Toledo fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Mercy Health - Saint Anne Hospital, Toledo
  • Mercy Health - Perrysburg Hospital, Perrysburg · Miili 8 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Site 06, Maumee · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07814248

DESTINY-PANTUMOUR04

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Research Site, Maumee · Miili 9 fagaatti
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • ProMedica Flower Hospital, Sylvania · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Namoota walitti qabaa jiraSadarkaa 3
  • Promedica Flower Hospital, Sylvania · Miili 9 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 15-Ful-2026 · NCT07214779

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Toledo Clinic Cancer Center, Toledo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Namoota walitti qabaa jiraSadarkaa 3
  • ProMedica Flower Hospital, Sylvania · Miili 9 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 26-Hag-2026 · NCT05281471

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Normunity Investigational Site, Maumee · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07182149

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Namoota walitti qabaa jira
  • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
  • ProMedica Flower Hospital, Sylvania · Miili 9 fagaatti
Umuriin 35 hanga 50 · Dubartoota · Haaromfame 07-Hag-2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
  • ProMedica Flower Hospital, Sylvania · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06580314

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Taylor Cancer Research Center, Maumee · Miili 9 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT04657068

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Namoota walitti qabaa jiraSadarkaa 2
  • Taylor Cancer Research Center, Maumee · Miili 9 fagaatti
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

Qorannoo Kansarii Ovarii magaalota biroo keessatti

Qorannoo biroo Toledo keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.